Trending Now
AlloVir’s (NASDAQ:ALVR) Receives IND Clearance For ALVR106 In Respiratory Disease and...
The US FDA has cleared AlloVir’s (NASDAQ:ALVR) Investigational New Drug (IND) application for ALVR106. ALVR106 is the company's off-the-shelf, allogeneic virus specific...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) Announces Its Q3 2020 Financial Results And...
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) has announced its Q3 2020 financial results and provided corporate updates.
Iovance moves lifileucel BLA submission to 2021
Maria Fardis, the company's...
MAKE IT MODERN
LATEST REVIEWS
Rolls-Royce (RYCEY) shares gain double digits post annual results
Rolls-Royce (OTCMKTS:RYCEY) shares rose by 23% on Thursday after the aviation manufacturer reported a 57% YoY increase in underlying profit for 2022,...
MAKE IT MODERN
PERFORMANCE TRAINING
A Snapshot Of Eyepoint Pharmaceuticals Inc’s (NASDAQ:EYPT) Performance In Q3 2020 Ahead Of 3Q...
Eyepoint Pharmaceuticals Inc (NASDAQ:EYPT) is slated to release its Q3 2020 financial and operational results, but it also recently released its Q3 performance highlights...
Atossa Therapeutics Inc. (NASDAQ: ATOS) Commences Enrollment In The Phase 2 Clinical Study of...
Atossa Therapeutics Inc. (NASDAQ: ATOS) has commenced enrolment in Phase 2 clinical trial of oral Z-Endoxifen in Sweden. Study participants will be premenopausal women...
After Big Q2 Win, What’s Next for ISWH?
ISW Holdings, a global brand management company, has been reporting continued improvement and also sequential quarterly growth.
The quarter ended June 30 disclosed substantial gains...
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) Commences ORLADEYO Shipment to US Patients for HAE Attacks Treatment
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) has announced that ORLADEYO™ (berotralstat) has received FDA approval and the company will start shipments to US patients...
Capricor Therapeutics (NASDA: CAPR) Enters Exclusive Agreement with Nippon Shinyaku Co. Ltd. on DMD...
Capricor Therapeutics (NASDA: CAPR) and Nippon Shinyaku Co. Ltd. have signed an exclusive distribution deal for CAP-1002 for Duchenne muscular dystrophy (DMD) treatment in...
MAKE IT MODERN
